VACCINOGEN
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases. It operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.
VACCINOGEN
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Frederick, Maryland, United States
Country:
United States
Website Url:
http://www.vaccinogeninc.com
Total Employee:
11+
Status:
Active
Contact:
301-668-8400
Email Addresses:
[email protected]
Total Funding:
99.05 M USD
Technology used in webpage:
BuyVM
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
FruitVaccine
FruitVaccine manufactures fruit-based vaccines to provide immunity against globally problematic infectious diseases.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Juvaris BioTherapeutics
Juvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.vaccinogeninc.com
- Host name: 104.21.96.1
- IP address: 104.21.96.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vaccinogen"
Vaccinogen 2025 Company Profile: Valuation, Funding โฆ
Information on valuation, funding, cap tables, investors, and executives for Vaccinogen. Use the PitchBook Platform to explore the full profile.See details»
Vaccinogen - Crunchbase Company Profile & Funding
Organization. Vaccinogen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email โฆSee details»
Vaccinogen - Wikipedia
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI. See details»
Vaccinogen Company Profile | Management and Employees List
Www.vaccinogeninc.com . Vaccinogen Profile and History. Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy โฆSee details»
Vaccinogen Company Profile - Craft
Vaccinogen is a biotechnology company specializing in personalized vaccines using a patient's immune system to fight cancer. It provides OncoVAX, an autologous cancer vaccine โฆSee details»
Vaccinogen, Inc. Company Profile | Baltimore, MD - Dun
Find company research, competitor information, contact details & financial data for Vaccinogen, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
Vaccinogen, Inc. | Frederick, MD, USA Startup - gust.com
Website vaccinogeninc.com; Company Summary Prevents recurrence of cancer by using the patient's own tumor to make a patient-specific vaccine. The first customers are those with stage II colon cancer followed by stage III, renal, โฆSee details»
Vaccinogen Inc. Company Profile | StatInvestor
Vaccinogen Company Profile. Learn more about who Vaccinogen is. Get financial information, who is the owner of Vaccinogen and key facts about Vaccinogen Inc.See details»
Working At Intracel Resources: Company Overview and Culture
Www.vaccinogeninc.com. Organization Type. Public. CEO. Andrew L. Tussing. Social Media. Vaccinogen, Inc. operates as a biotechnology company that develops OncoVAX, an Active โฆSee details»
Vaccinogen - Wikiwand
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used โฆSee details»
Oncology Companies, Vaccinogen, Inc. (Private)
Www.vaccinogeninc.com Vaccinogen, Inc. is a cancer vaccine company developing OncoVAX®, a patient specific therapy to prevent the recurrence of colon cancer and potentially other solid โฆSee details»
Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as โฆ
BALTIMORE, May 5, 2015 /PRNewswire/ -- Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today announced that its Board of Directors has โฆSee details»
Vaccinogen, Inc. in Baltimore, MD - (410) 387-4000 - Company โฆ
Vaccinogen, Inc. (trade name Vaccinogen) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Vaccinogen Lands $80M - VC News Daily
For additional information on the TIS financing and related management and board reorganization, please refer to the Company's Current Reports on Form 8-K filed on April 28, โฆSee details»
Vaccinogen - VentureRadar
Vaccinogen, Inc. is a cancer vaccine company that is clinically testing its OncoVAX treatment which is designed to prevent the recurrence of colon... ... Find out ...See details»
Vaccinogen Selects Clinipace Worldwide to Manage Global Phase โฆ
May 5, 2010 MORRISVILLE, N.C.--(BUSINESS WIRE)-- Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a โฆSee details»
Vaccinogen - Company Profile | ConnectFlux
Company Metrics. Employees: 11-50 Monthly Visits: None Tech Stack: 13 active products Financial Information. Estimated Revenue: $10M to $50M Total Funding: 99051350 USD Last โฆSee details»
Vaccinogen - 2025 Company Profile, Funding & Competitors
Mar 21, 2025 Vaccinogen - Autologous cancer vaccine for the post-surgical treatment of Stage II colon cancer.. Public Company. Raised a total funding of $11.6M over 7 rounds from 1 โฆSee details»
Statement on the antigen composition of COVID-19 vaccines
14 hours ago The TAG-CO-VAC reconvened on 6-7 May 2025 to review the genetic and antigenic evolution of SARS-CoV-2; immune responses to SARS-CoV-2 infection and/or โฆSee details»
Vaccinogen, Inc. (Vaccinogen, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่ โฆ
OncoVAX® is the first cancer vaccine that both prevents cancer recurrence and addresses the diversity of cancer cells. In this pivotal randomized, multicenter Phase IIIb study in patients โฆSee details»